Arachidonic Acid Kills Staphylococcus aureus through a Lipid Peroxidation Mechanism
William N Beavers1, Andrew J Monteith1, Venkataraman Amarnath1
1Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Arachidonic acid (AA) kills Staphylococcus aureus via lipid peroxidation, damaging bacterial macromolecules. Resistance to AA toxicity in a mutant strain increases susceptibility to antibiotics and reduces virulence, highlighting a potential therapeutic target.
Area of Science:
- Microbiology
- Biochemistry
- Immunology
Background:
- Staphylococcus aureus is a significant human pathogen.
- Vertebrates produce antimicrobial compounds, including polyunsaturated fatty acids, to combat bacterial infections.
- Arachidonic acid (AA) is an abundant polyunsaturated fatty acid released during the oxidative burst, known to be toxic to S. aureus.
Purpose of the Study:
- To elucidate the mechanism by which arachidonic acid (AA) exerts toxicity against Staphylococcus aureus.
- To investigate the consequences of S. aureus resistance to AA toxicity.
Main Methods:
- Investigated the mechanism of AA toxicity in S. aureus.
- Utilized a genetically inactivated S. aureus strain (USA300 ΔlcpA mutant) with reduced reactive oxygen species production.
- Assessed the impact of AA resistance on bacterial susceptibility to beta-lactam antibiotics and virulence in a murine infection model.
Main Results:
- Arachidonic acid (AA) kills S. aureus through a lipid peroxidation mechanism, generating reactive electrophiles that modify bacterial macromolecules.
- Antioxidants and the ΔlcpA mutation rescued S. aureus from AA-induced toxicity.
- S. aureus mutants resistant to AA exhibited increased susceptibility to beta-lactam antibiotics and attenuated virulence in vivo.
Conclusions:
- Lipid peroxidation is the mechanism underlying arachidonic acid toxicity to S. aureus.
- Resistance to AA toxicity confers a fitness cost, increasing susceptibility to other host stressors.
- Targeting the lipid peroxidation pathway presents a potential therapeutic strategy against S. aureus infections.
More Related Videos
12:27Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Biosynthesis of Lipids
Radical Autoxidation
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Formation of Lipopolysaccharides
Gene Regulation in Microbial Communities: Quorum Sensing
